Penile bulb dose and impotence after three-dimensional conformal radiotherapy for prostate cancer on RTOG 9406: findings from a prospective, multi-institutional, phase I/II dose-escalation study.

@article{Roach2004PenileBD,
  title={Penile bulb dose and impotence after three-dimensional conformal radiotherapy for prostate cancer on RTOG 9406: findings from a prospective, multi-institutional, phase I/II dose-escalation study.},
  author={Mack Roach and Kathryn Winter and Jeffrey M Michalski and James D. Cox and James A. Purdy and Walter Bosch and Xiao Lin and William S Shipley},
  journal={International journal of radiation oncology, biology, physics},
  year={2004},
  volume={60 5},
  pages={1351-6}
}
PURPOSE To assess the relationship between the dose to the bulb of the penis and the risk of impotence in men treated on Radiation Therapy Oncology Group (RTOG) 9406. METHODS AND MATERIALS Men enrolled on a Phase I/II dose-escalation study, RTOG 9406, who were reported to be potent at entry and evaluable (n = 158) were selected for inclusion. Follow-up evaluations were scheduled every 3, 4, and 6 months for the first, second, and the third through fifth years, then annually. At each follow-up… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 36 extracted citations

Radiation-induced erectile dysfunction: Recent advances and future directions

Advances in radiation oncology • 2016
View 2 Excerpts
Highly Influenced

Penile bulb sparing in prostate cancer radiotherapy

Strahlentherapie und Onkologie • 2018
View 1 Excerpt

Pelvic Radiation and Normal Tissue Toxicity.

Seminars in radiation oncology • 2017
View 1 Excerpt

Similar Papers

Loading similar papers…